Ascentage Pharma Group International (36X0.F) Q3 2026 Earnings

18AugConfirmed
Q1 2025
Q3 2025
Q1 2026
Q3 2026
-0.28
-0.18
-0.09
0

Details

Expected EPS
-0.0477131114756472
Actual EPS
-0.278494555284
Surprise EPS
-0.23
Surprise Percent
+483.69%

Description

Ascentage Pharma Group International (36X0.F) has reported earnings of -0.278494555284 per share for Q3 2026.

0 Comments

Share your thoughts